Transaction #25531 · Form 4 · 0001193125-25-335538
CORCEPT THERAPEUTICS INC · Other acquisition · Common Stock
CORCEPT THERAPEUTICS INC · Transacted December 24, 2025 · Filed December 29, 2025
What does this filing report?
An SEC Form 4 filing for CORCEPT THERAPEUTICS INC records an other acquisition involving Common Stock on December 24, 2025. The reported quantity was 243,154. The filing date is December 29, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- CORCEPT THERAPEUTICS INC
- Company CIK
- 0001088856
- Security type
- Non-derivative
- Acquisition type
- Other acquisition · Code J
- Quantity acquired
- 243,154
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 2,944,524
- Ownership description
- Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02
- SEC acceptance time
- Dec 29, 2025, 5:24 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- BELANOFF JOSEPH K ↗
Chief Executive Officer · Director
CIK 0001286199
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability from a net (cashless) exercise of options.
- F2
- Transfer of shares without consideration to the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02.
- F3
- Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
- F4
- Fully exercisable.
Remarks
The power of attorney under which this form was signed is on file with the Commission.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.